# Novocol Pharmaceutical of Canada, Inc. - Inspection Records Source: https://www.globalkeysolutions.net/companies/novocol-pharmaceutical-of-canada-inc/28ac0d84-7b4b-4be0-96a8-9daeafbb5ac3 > Inspection records and compliance data for Novocol Pharmaceutical of Canada, Inc. in Cambridge, None. Access full analysis and detailed observations. --- ## Details - Name: Novocol Pharmaceutical of Canada, Inc. - FEI Number: 3002807757 - Canada Business Number: 103950481 - City: Cambridge - State: None - Country Name: Canada - Address Line 1: 25 Wolseley Crt - Zip Code: None - Business Operations: FDF MANUFACTURE ## Related Documents - [Canada Inspection - Novocol Pharmaceutical of Canada, Inc. - Inspection #87996 - 2025-12-02](https://www.globalkeysolutions.net/records/canada_inspection/novocol-pharmaceutical-of-canada-inc/6f104d9d-1de9-4fe7-9404-8781fb90151f) — source: Canada, date: December 2, 2025 - [Canada Inspection - Novocol Pharmaceutical of Canada, Inc. - Inspection #87995 - 2025-12-02](https://www.globalkeysolutions.net/records/canada_inspection/novocol-pharmaceutical-of-canada-inc/fb152eca-af01-4874-9baf-97f7b6c08e25) — source: Canada, date: December 2, 2025 - [Canada Inspection - Novocol Pharmaceutical of Canada, Inc. - Inspection #85319 - 2024-11-12](https://www.globalkeysolutions.net/records/canada_inspection/novocol-pharmaceutical-of-canada-inc/507d3f80-1923-4cec-a584-de8f088226fc) — source: Canada, date: November 12, 2024 - [Canada Inspection - Novocol Pharmaceutical of Canada, Inc. - Inspection #85318 - 2024-11-12](https://www.globalkeysolutions.net/records/canada_inspection/novocol-pharmaceutical-of-canada-inc/643c38cc-ae99-4189-8139-9b88ae9d2648) — source: Canada, date: November 12, 2024 - [Canada Inspection - Novocol Pharmaceutical of Canada, Inc. - Inspection #85109 - 2024-11-12](https://www.globalkeysolutions.net/records/canada_inspection/novocol-pharmaceutical-of-canada-inc/75572f3c-0f05-41c2-a9c9-505945cdb3d3) — source: Canada, date: November 12, 2024 - [FDA Inspection 1243223 - Novocol Pharmaceutical of Canada, Inc. - 2024-05-03](https://www.globalkeysolutions.net/records/fda_inspections/novocol-pharmaceutical-of-canada-inc/3dac8b8a-a0c6-47a8-bbc7-1b7abde85610) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 3, 2024 - [Canada Inspection - Novocol Pharmaceutical of Canada, Inc. - Inspection #81935 - 2023-10-26](https://www.globalkeysolutions.net/records/canada_inspection/novocol-pharmaceutical-of-canada-inc/ce7ea35d-f39b-484c-ac8a-e75c53264644) — source: Canada, date: October 26, 2023 - [Canada Inspection - Novocol Pharmaceutical of Canada, Inc. - Inspection #81934 - 2023-10-23](https://www.globalkeysolutions.net/records/canada_inspection/novocol-pharmaceutical-of-canada-inc/0c442c67-67b6-435d-ba4c-dde256e93c8d) — source: Canada, date: October 23, 2023 - [Canada Inspection - Novocol Pharmaceutical of Canada, Inc. - Inspection #80570 - 2023-05-23](https://www.globalkeysolutions.net/records/canada_inspection/novocol-pharmaceutical-of-canada-inc/3aaa6f8f-d0fe-43f0-adac-dc394932e411) — source: Canada, date: May 23, 2023 - [Canada Inspection - Novocol Pharmaceutical of Canada, Inc. - Inspection #77446 - 2021-11-08](https://www.globalkeysolutions.net/records/canada_inspection/novocol-pharmaceutical-of-canada-inc/98edaf7c-212e-4feb-bdfe-da218cd3b965) — source: Canada, date: November 8, 2021 - [Canada Inspection - Novocol Pharmaceutical of Canada, Inc. - Inspection #77445 - 2021-11-08](https://www.globalkeysolutions.net/records/canada_inspection/novocol-pharmaceutical-of-canada-inc/535590e6-d7c9-4ac9-bd76-d7c2a03dfec4) — source: Canada, date: November 8, 2021 - [FDA Inspection 1117454 - Novocol Pharmaceutical of Canada, Inc. - 2020-01-30](https://www.globalkeysolutions.net/records/fda_inspections/novocol-pharmaceutical-of-canada-inc/56a13d22-13af-4391-ac19-fcf470373a23) — classification: No Action Indicated (NAI), source: FDA, date: January 30, 2020 - [FDA Inspection 1098218 - Novocol Pharmaceutical of Canada, Inc. - 2019-06-21](https://www.globalkeysolutions.net/records/fda_inspections/novocol-pharmaceutical-of-canada-inc/ad22248b-7a06-4bc0-9f3b-09b415e21691) — classification: No Action Indicated (NAI), source: FDA, date: June 21, 2019 - [483 - Novocol Pharmaceutical of Canada, Inc. - 2019-06-18](https://www.globalkeysolutions.net/records/483/novocol-pharmaceutical-of-canada-inc/7485559c-7f8a-451d-a20e-1683858db483) — source: FDA, date: June 18, 2019 - [FDA Inspection 1093310 - Novocol Pharmaceutical of Canada, Inc. - 2019-06-18](https://www.globalkeysolutions.net/records/fda_inspections/novocol-pharmaceutical-of-canada-inc/5a9546ca-45e2-4264-a4d2-5e3257507745) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 18, 2019 - [FDA Inspection 1019963 - Novocol Pharmaceutical of Canada, Inc. - 2017-07-26](https://www.globalkeysolutions.net/records/fda_inspections/novocol-pharmaceutical-of-canada-inc/3bb110fa-3de8-4981-beb5-7bd94a5b4525) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 26, 2017 - [FDA Inspection 1012538 - Novocol Pharmaceutical of Canada, Inc. - 2017-05-16](https://www.globalkeysolutions.net/records/fda_inspections/novocol-pharmaceutical-of-canada-inc/978488c1-3312-4f19-89c3-05d5294aa4a8) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 16, 2017 - [FDA Inspection 942576 - Novocol Pharmaceutical of Canada, Inc. - 2015-08-11](https://www.globalkeysolutions.net/records/fda_inspections/novocol-pharmaceutical-of-canada-inc/ded16020-68dd-43cf-b10a-579ab46651c7) — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 11, 2015 - [FDA Inspection 903515 - Novocol Pharmaceutical of Canada, Inc. - 2014-11-11](https://www.globalkeysolutions.net/records/fda_inspections/novocol-pharmaceutical-of-canada-inc/8969b71e-27c5-4a74-b70b-f807c0913bfc) — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 11, 2014 - [FDA Inspection 778882 - Novocol Pharmaceutical of Canada, Inc. - 2012-04-20](https://www.globalkeysolutions.net/records/fda_inspections/novocol-pharmaceutical-of-canada-inc/4fb1e9f6-68a9-41b8-8d66-7a140961369f) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 20, 2012 ## Related Companies - [Taro Pharmaceuticals Inc.](https://www.globalkeysolutions.net/companies/taro-pharmaceuticals-inc/2072a3d5-a0ae-4bb7-9375-a6406a4fd768) - [Church & Dwight Canada Corp.](https://www.globalkeysolutions.net/companies/church-dwight-canada-corp/cbcb0b61-bee8-4359-88e4-831475253c5b) - [Odan Laboratories Ltd](https://www.globalkeysolutions.net/companies/odan-laboratories-ltd/00e302de-b81d-482e-b486-cf23e1cd0747) - [Diversey Canada, Inc.](https://www.globalkeysolutions.net/companies/diversey-canada-inc/08a08842-7884-4417-bc84-a625d0dae16d) - [Pharmascience Inc.](https://www.globalkeysolutions.net/companies/pharmascience-inc/97570728-d9d7-40ba-a5ec-3e0b006c3182) - [Haemotec, a division of Fresenius Medical Care Canada Inc.](https://www.globalkeysolutions.net/companies/haemotec-a-division-of-fresenius-medical-care-canada-inc/e9e11d8b-4730-4933-bdc6-0a4687ed47ac) - [Pharmascience Inc.](https://www.globalkeysolutions.net/companies/pharmascience-inc/2fa6f1e7-a980-4d37-b8d0-daf9e3a309c4) - [Estee Lauder Cosmetics Ltd.](https://www.globalkeysolutions.net/companies/estee-lauder-cosmetics-ltd/81ad9c58-47f9-4cd7-b2f3-aa4f89ddb2ac) - [Voyant Beauty, Inc.](https://www.globalkeysolutions.net/companies/voyant-beauty-inc/881e2944-36f2-4984-9ca9-319b61788b64) - [Bausch Health Companies Inc.](https://www.globalkeysolutions.net/companies/bausch-health-companies-inc/3190f4ed-695e-491f-a57e-1ef128f7e2af) ## Related Officers - [Bei Y. He](https://www.globalkeysolutions.net/people/bei-y-he/6ee057b7-9558-4f4c-b312-9a63821699c2)